Abstract:
The methanol extracts and solvent soluble fractions of three selected plant species
[Nepeta laevigata, Nepeta kurramensis and Rhynchosia reniformis] were evaluated for
their antimicrobial, antiglycation, antiplatelet aggregation, antioxidant, cytotoxicity,
phytotoxic activities, proximate compositions and isolation of natural products, for the
intention of standardization and proper manage of bioactive principles in such
heterogonous botanicals and encourage drug finding work with plants.
The antibacterial results of Nepeta laevigata showed that the n-butanol fraction exhibited
potential activity (85 % inhibition) against Escherichia coli and Proteus morganii (83 %
inhibition), while in Nepeta kurramensis chloroform fraction exhibited promising activity
(89 % inhibition) against Streptococcus cricetus, and Micrococcus flavas (84 %
inhibition). In Rhynchosia reniformis, only crude extract exhibited 100% inhibition
against Streptococcus cricitus while ethyl acetate fraction showed (99 % inhibition)
against Micrococcus flavas, Streptococcus cricitus (95 % inhibition), and Proteus
morganii (90 % inhibition). In antifungal activities; chloroform and ethyl acetate
fractions of Nepeta laevigata as well as chloroform fraction of Nepeta kurramensis were
promising; while in Rhynchosia reniformis chloroform, n-hexane and methanolic extracts
were significant inhibitors as compared to rest of fractions.
The fractions n-hexane and ethyl acetate of Nepeta laevigata demonstrated significant
antiglycation activity with 71.26 % and 74.02 % inhibition and for Nepeta kurramensis
67.24 % inhibition was shown only by the n-hexane fraction. Among Rhynchosia
reniformis fractions, ethyl acetate and chloroform displayed a significant antiglycation
profile with 70.27 % and 76.02 % inhibition against protein glycation, respectively, while
n-hexane fraction illustrated a moderate 64.06 % inhibition.
In antiplatelet actions of Rhynchosia reniformis the water fraction was only dynamic
against platelet activating factor (PAF) stimulate human platelet aggregation. Methanolic
and n-butanol fractions exhibited potential activities against arachidonic acid (AA) and
PAF while other fractions were insignificant and in platelet aggregation activity ofNepeta plants crude extract, chloroform and n-hexane fractions showed significant
activity.
The antioxidant potential of the crude extract and various fractions of Rhynchosia was
assessed by using free radicals such as hydroxyl ( • OH) radical, total reactive oxygen
species (ROS) and to scavenge authentic nitric oxides (ONOO - ). The Chloroform-soluble
fraction was noted to contain a maximum amount of poly phenolic compounds acting as
antioxidants (with IC 50 values of 30.24±0.07, 93.89±0.09 and 23.50±0.02, for scavenge
authentic ONOO - , total ROS and to • OH radical, respectively) and established to be more
efficient than crude extract and the other successive fractions. The ethyl acetate fraction
of Nepeta laevigata exhibited stronger antioxidative profile with IC 50 values of
88.37±0.05 and 30.42±0.04, 55.97±0.09 for total ROS, • OH radical and to scavenge
authentic ONOO - , respectively. Similar antioxidant profile was observed in Nepeta
kurramensis.
The fraction n-butanol of Rhynchosia reniformis showed potential cytotoxic activities
while rests of the fractions were found to be inactive. No lethal activities were exhibited
by Nepeta plants fractions. Surprisingly none of the fraction of all three plants under
investigation exhibited phytotoxic activities.
The proximate composition of the selected medicinal plants was assessed and analyzed
according to AOAC methods. All the selected species were found to be a good source of
ash, proteins and fats which can contribute greatly towards nutritional requirements and
adequate protection against microorganism and other diseases.
As a result of phytochemical investigation of Nepeta kurramensis seven pure compounds
(1-7) were isolated out of which compound (1) is a new isolate and is named as
Kurramenate after the plant species name. Two known flavonoids (8 and 9) have been
provided by Rhynchosia reniformis. The compounds structures were confirmed on the
basis of preliminary chemical tests and nuclear magnetic resonance (NMR) studies.O
1
3
4
5
6
OH
32'
2
1' O 3'
1'' O 3''
4'
5''
4''
32''
O
6'
5'
6''
7'
7''
10'-25' 26'
8'
9'
27'
26''
9''
8''
27''
28''
29''
23'
31'
29'
2
3
1
30'' 31'' 4
6
1' O
1'' O
3'
9'-18'
7'
5'
4'
6'
4''
3''
10''-25''
OH
24'
O
30'
28'
5''
8'
7''
6''
19''
20''
21''
22''
9''-18''
23''
O
21'
19'
8''
22'
20'
24''
bis(2-ethylicosyl) phthalate (2)
Kurramenate (1)
OH
OH
1-nonacosanol (4)
1-dotriacontanol (3)
COOH
HO
HO
HO
Ursolic acid (5)
H 3 C
5 \
6 \
O
8
H 3 C
O
1 \
O
1
7
6
4
5
OH
2
3
O
4 \
H 3 C
CH 3
2
O
CH 3
5-hydroxy-3,6,8,4 -tetramethoxyflavon (8)
5 \
O
1 \
O
1
7
H 3 C
6 \
O
8
3 \
\
6
O
`
-sitosterol (7)
-amyrin (6)
4
5
OH
2
3
OH
4 \
3 \
2 \
OH
O
`
3,5,4 -trihydroxy-6,8-dimethoxyflavone (9)
Compounds 1, 2, 8 and 9 exhibited moderate antimicrobial and antioxidative activities.
The biologically active crude extracts, fractions and pure compounds can be used for the
curing of microbial diseases, glycation, artery and oxygen stress allied syndromes.
However, further in vivo examination of crude extracts, fractions and pure compounds
will discover its potential pharmaceutical actions.